These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8464958)

  • 21. Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
    Stewart DE; Fairman M; Barbadoro S; Zownir P; Steiner M
    Biol Psychiatry; 1994 Aug; 36(3):201-2. PubMed ID: 7948458
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolactin and sodium lactate-induced panic.
    Hollander E; Liebowitz MR; Cohen B; Gorman JM; Fyer AJ; Papp LA; Klein DF
    Psychiatry Res; 1989 May; 28(2):181-91. PubMed ID: 2748770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consistencies between recalled panic and lactate-induced panic.
    Goetz RR; Klein DF; Gorman JM
    Anxiety; 1994; 1(1):31-6. PubMed ID: 9160544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism.
    Gorman JM; Kent J; Martinez J; Browne S; Coplan J; Papp LA
    Arch Gen Psychiatry; 2001 Feb; 58(2):125-31. PubMed ID: 11177114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertonic saline infusion induces panic in patients with panic disorder.
    Jensen CF; Peskind ER; Veith RC; Hughes J; Cowley DS; Roy-Byrne P; Raskind MA
    Biol Psychiatry; 1991 Sep; 30(6):628-30. PubMed ID: 1932411
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
    Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
    Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder.
    Batra NA; Seres-Mailo J; Hanstock C; Seres P; Khudabux J; Bellavance F; Baker G; Allen P; Tibbo P; Hui E; Le Melledo JM
    Biol Psychiatry; 2008 Jun; 63(12):1178-84. PubMed ID: 18061146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of severity of panic disorder and neuroanatomical changes on magnetic resonance imaging.
    Ontiveros A; Fontaine R; Breton G; Elie R; Fontaine S; Déry R
    J Neuropsychiatry Clin Neurosci; 1989; 1(4):404-8. PubMed ID: 2521092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations.
    Gallant SJ; Popiel DA; Hoffman DM; Chakraborty PK; Hamilton JA
    Psychosom Med; 1992; 54(2):149-66. PubMed ID: 1565753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria.
    Harrison WM; Sandberg D; Gorman JM; Fyer M; Nee J; Uy J; Endicott J
    Psychiatry Res; 1989 Feb; 27(2):183-92. PubMed ID: 2496414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late luteal phase dysphoric disorder and DSM-III-R.
    Spitzer RL; Severino SK; Williams JB; Parry BL
    Am J Psychiatry; 1989 Jul; 146(7):892-7. PubMed ID: 2742015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder.
    Halbreich U; Petty F; Yonkers K; Kramer GL; Rush AJ; Bibi KW
    Am J Psychiatry; 1996 May; 153(5):718-20. PubMed ID: 8615423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is premenstrual dysphoria a variant of panic disorder? A review.
    Vickers K; McNally RJ
    Clin Psychol Rev; 2004 Dec; 24(8):933-56. PubMed ID: 15533279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortisol response during different anxiogenic challenges in panic disorder patients.
    Targum SD
    Psychoneuroendocrinology; 1992 Oct; 17(5):453-8. PubMed ID: 1484913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder.
    Nyberg S; Wahlström G; Bäckström T; Sundström Poromaa I
    Psychoneuroendocrinology; 2004 Jul; 29(6):767-77. PubMed ID: 15110926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptoms essential to the experience of sodium lactate-induced panic.
    Goetz RR; Klein DF; Gorman JM
    Neuropsychopharmacology; 1996 May; 14(5):355-66. PubMed ID: 8703304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactate sensitivity and cardiac cholinergic function in panic disorder.
    Yeragani VK; Srinivasan K; Balon R; Ramesh C; Berchou R
    Am J Psychiatry; 1994 Aug; 151(8):1226-8. PubMed ID: 8037261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.
    Le Mellédo JM; Merani S; Koszycki D; Bellavance F; Palmour R; Gutkowska J; Steinberg S; Bichet DG; Bradwejn J
    Neuropsychopharmacology; 1999 Jan; 20(1):81-91. PubMed ID: 9885787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.